RARB genetic variants might contribute to the risk of chronic obstructive pulmonary disease based on a case-control study
2024

RARB Genetic Variants and COPD Risk

Sample size: 541 publication 10 minutes Evidence: moderate

Author Information

Author(s): L. Huang, W. Xu, Y. Fu, Z. Yang, R. Mo, Y. Ding, T. Xie

Primary Institution: Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University

Hypothesis

The study aims to evaluate the association between RARB SNPs and COPD risk.

Conclusion

The study suggests that RARB SNPs may influence the risk of developing COPD.

Supporting Evidence

  • Significant association found between rs6799734 and COPD susceptibility.
  • Stratified analysis showed increased risk in individuals aged ≤ 71 years, males, those with BMI ≥ 24, and smokers.
  • rs1286641 and rs1881706 were associated with COPD risk in females and smokers.

Takeaway

This study looks at how certain genes might make people more likely to get a lung disease called COPD.

Methodology

A case-control study involving 270 COPD patients and 271 healthy controls, with SNP genotyping performed using the MassARRAY iPLEX platform and association analyzed using logistic regression.

Potential Biases

Potential bias due to the study being limited to one ethnic group and the relatively small sample size.

Limitations

The sample size is relatively small for genetic association studies and limited to Han Chinese ethnicity, which may affect generalizability.

Participant Demographics

270 COPD patients (64 females, 206 males) and 271 healthy controls (61 females, 210 males), all of Chinese Han ethnicity.

Statistical Information

P-Value

0.008

Confidence Interval

95% CI = 1.03-1.68

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1080/07853890.2024.2445195

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication